The cost-effectiveness of IIb/IIIa platelet receptor inhibitors in patients with acute myocardial infarction treated with percutaneous angioplasty | Charles Explorer

The cost-effectiveness of IIb/IIIa platelet receptor inhibitors in patients with acute myocardial infarction treated with percutaneous angioplasty

Publikace

Abstrakt

PTCA, Platelet receptor IIb/IIIa

Osoby